Ventana Medical Systems
Mary Gleason is an accomplished professional with extensive experience in laboratory management, assay development, and project leadership within the biotechnology and pharmaceutical sectors. Currently serving as Lab Operations Manager at Roche since November 2020, Mary oversees a CAP/CLIA laboratory specializing in clinical trial testing, supervising a team of 20 and ensuring high-quality results for pharmaceutical clients. Previously, Mary held several positions at Ventana Medical Systems, including Senior Scientist, where technical leadership in developing a liquid-based cytology preservative and multiplexing IVD assays was demonstrated. Mary also contributed to advanced staining platform development and reagent feasibility for various staining techniques. Earlier roles at Roche included Project Manager and Program Manager, focusing on setting up clinical testing laboratories and managing complex clinical and lab services projects. Mary began their career at the University of Arizona, managing research laboratories and engaging in various molecular biology techniques. Mary holds a Bachelor's degree in Medical Microbiology and Immunology from the University of Wisconsin-Madison.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.